Related references
Note: Only part of the references are listed.Treatment of Clostridioides difficile Infection and Non-compliance with Treatment Guidelines in Adults in 10 US Geographical Locations, 2013-2015
Shannon A. Novosad et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2020)
Estimating the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections in the United States Using Antibiotic Prescription Data
Cornelius J. Clancy et al.
OPEN FORUM INFECTIOUS DISEASES (2019)
Estimating the Size of the US Market for New Antibiotics with Activity against Carbapenem-Resistant Enterobacteriaceae
Cornelius J. Clancy et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Charting the Path Forward: Development, Goals and Initiatives of the 2019 Infectious Diseases of America Strategic Plan
Cynthia L. Sears et al.
CLINICAL INFECTIOUS DISEASES (2019)
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
L. Clifford McDonald et al.
CLINICAL INFECTIOUS DISEASES (2018)
Evaluation of fidaxomicin usage patterns and outcomes for Clostridium difficile infection across the United States Veterans Health Administration
S. E. Giancola et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2018)
Lack of adherence to SHEA-IDSA treatment guidelines for Clostridium difficile infection is associated with increased mortality
I. Patel et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Compliance with Clostridium difficile treatment guidelines: effect on patient outcomes
K. T. Crowell et al.
EPIDEMIOLOGY AND INFECTION (2017)
Clinical Practice Guidelines: A Primer on Development and Dissemination
M. Hassan Murad
MAYO CLINIC PROCEEDINGS (2017)
Bezlotoxumab - A New Agent for Clostridium difficile Infection
John G. Bartlett
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Risk Factors for Community-Associated Clostridium difficile Infection in Adults: A Case-Control Study
Alice Y. Guh et al.
OPEN FORUM INFECTIOUS DISEASES (2017)
Economic Barriers in the Treatment of Clostridium difficile Infection With Oral Vancomycin
Kristen L. Bunnell et al.
OPEN FORUM INFECTIOUS DISEASES (2017)
Impact of Evidence-Based Guidelines on Outcomes of Hospitalized Patients With Clostridium difficile Infection
Stephen J. Knaus et al.
SOUTHERN MEDICAL JOURNAL (2016)
Effect of Treatment Variation on Outcomes in Patients with Clostridium difficile
Adam T. Brown et al.
AMERICAN JOURNAL OF MEDICINE (2014)
Vancomycin, Metronidazole, or Tolevamer for Clostridium difficile Infection: Results From Two Multinational, Randomized, Controlled Trials
Stuart Johnson et al.
CLINICAL INFECTIOUS DISEASES (2014)
High Frequency of Nonadherence to Clostridium difficile Treatment Guidelines
M. Catherine McEllistrem et al.
SOUTHERN MEDICAL JOURNAL (2014)
Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial
Oliver A. Cornely et al.
LANCET INFECTIOUS DISEASES (2012)
Lack of Health Insurance Coverage for Oral Vancomycin: It's Time to Tackle the Elephant in the Room
Alex Studemeister
CLINICAL INFECTIOUS DISEASES (2011)
A randomized, double-blind, placebo-controlled pilot study to assess the ability of rifaximin to prevent recurrent diarrhoea in patients with Clostridium difficile infection
Kevin W. Garey et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Fidaxomicin versus Vancomycin for Clostridium difficile Infection
Thomas J. Louie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)
Stuart H. Cohen et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2010)
Effects of evidence-based clinical practice guidelines on quality of care: a systematic review
M. Lugtenberg et al.
QUALITY & SAFETY IN HEALTH CARE (2009)
Share Paper
